Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
adverse drug reaction
bacterial infection
cerebrovascular accident
cerebrovascular accident, mimics
chlorpropamide
coma
diabetes mellitus
drug induced neurologic disorders
genetic neurologic disorders
hemiparesis
hypoglycemia
hypoglycemic agent, oral
hypoglycemic coma
iatrogenic neurologic disorders
insulin
level of consciousness, decreased
mimics
mortality
old age, neurology of
optic neuropathy
optic neuropathy, toxic
seizure
tolazamide
transketolase
visual loss
Wernicke's encephalopathy
Showing articles 1800 to 1850 of 4563 << Previous Next >>

Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
Clin Inf Dis 41:634-653, Roden, M.M.,et al, 2005

Hypoattenuation on CT Angiographic Source Images Predicts Risk of Intracerebral Hemorrhage and Outcome After Intra-Arterial Reperfusion Therapy
AJNR 26:1798-1803, Schwamm,L.,et al, 2005

Chasing "Chasing the Dragon" with MRI: Leukoencephalopathy in Drug Abuse
Br J Radiol 78:997-1004, Bartlett,E. &Mikulis,D.J., 2005

Underappreciated Statin-Induced Myopathic Weakness Causes Disability
Neurorehabil Neural Repair 19:259-263, Dobkin,B.H., 2005

Reversible Posterior Leukoencephalopathy Syndrome
Intern Med J 35:83-90, Stott,V.L.,et al, 2005

The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): A Phase II MRI-Based 9-Hour Window Acute Stroke Thrombolysis Trial With Intravenous Desmoteplase
Stroke 36:66-73, Hacke,W.,et al, 2005

Clinical Features and Diagnosis of Primary Central Nervous System Lymphoma
Hematol Oncol Clin North Am 19:689-703, Fitzsimmons,A.,et al, 2005

Update on Susacs Syndrome
Curr Opin Neurol 18:311-314, Gross,M. &Eliashar,R., 2005

Capecitabine-Induced Multifocal Leukoencephalopathy: A Report of Five Cases
Neurol 65:1792-1794, Videnovic,A.,et al, 2005

Thrombolysis in Stroke Patients Aged 80 Years and Older: Swiss Survey of IV Thrombolysis
Neurol 65:1795-1798,1690, Engelter,S.T.,et al, 2005

Is Hospitalization After TIA Cost-Effective on the Basis of Treatment With tPA?
Neurol 65:1799-1801, Nguyen-Huynh,M.N. &Johnson,S.C., 2005

Clinical Importance of Microbleeds in Patients Receiving IV Thrombolysis
Neurol 65:1175-1178, Kakuda,W.,et al, 2005

Reversible Anorgasmia With Topiramate Therapy for Migraine
Neurol 65:1333-1334, Newman,L.C.,et al, 2005

Perfusion Computed Tomography: Prediction of Final Infarct Extent and Stroke Outcome
Ann Neurol 58:672-679,661, Parsons,M.W.,et al, 2005

Economic Benefit of Increasing Utilization of Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke in the United States
Stroke 36:2500-2503, Demaerschalk,B.M. &Yip,T.R., 2005

Poor Outcomes in Patients Who Do Not Receive Intravenous Tissue Plasminogen Activator Because of Mild or Improving Ischemic Stroke
Stroke 36:2497-2499, Smith,E.E.,et al, 2005

Outcome and Severe Hemorrhagic Complications of Intravenous Thrombolysis With Tissue Plasminogen Activator in Very Old (=80 Years) Stroke Patients
Stroke 36:2421-2425, Berrouschot,J.,et al, 2005

Anticoagulants Versus Antiplatelet Therapy for Preventing Stroke in Patients with Nonrheumatic ATrial Fibrillation and a History of Stroke or Transient Ischemic Attack
Stroke 36:914-915, Saxena,R. &Koudstaal,P.J., 2005

Intravenous rt-PA for Acute Stroke: Comparing Its Effectiveness in Younger and Older Patients
JNNP 76:1234-1237, Mouradian,M.S.,et al, 2005

Evaluation of Combination Therapy Using Aciclovir and Corticosteroid in Adult Patients with Herpes Simplex Virus Encephalitis
JNNP 76:1544-1549,1469, Kamei,S.,et al, 2005

Delayed Neurotoxicity in Primary Central Nervous System Lymphoma
Arch Neurol 62:1595-1600, Omuro,A.M.P.,et al, 2005

Antiplatelet Therapy Contributes to Acute Deterioration of Intracerebral Hemorrhave
Neurol 65:1000-1004, Toyoda,K.,et al, 2005

Current Concepts in the Etiology and Treatment of Behcet Disease
Surv Ophthalmol 50:297-350, Evereklioglu,C., 2005

Efficacy and Safety of Cholesterol-Lowering Treatment: Prospective Meta-Analysis of Data from 90056 Participants in 14 Randomised Trials of Statins
Lancet 366:1267-1278, Cholesterol Treatment Trialists (CTT) Collaborators, 2005

Infliximab and Reactivation of Cerebral Toxoplasmosis
NEJM 353:1530-1531, Callegari,P.E., 2005

Statins Are Associated With Better Outcomes After Carotid Endarterectomy in Symptomatic Patients
Stroke 36:2072-2076,2058, Kennedy,J.,et al, 2005

Addition of Clopidogrel to Aspirin in 45852 Patients With Acute Myocardial Infarction: Randomised Placebo-Controlled Trial
Lancet 366:1607-1621, COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group, 2005

Statins and Cognitive Functioning the Elderly
Neurol 65:1388-1394, Bernick,C.,et al, 2005

Rhabdomyolysis: An Evaluation of 475 Hospitalized Patients
Medicine 84:377-385, Melli,G.,et al, 2005

Lipid Lowering Agents Are Associated With a Slower Cognitive Decline in Alzheimers Disease
JNNP 76:1624-1629, Masse,I.,et al, 2005

Diffusion-Weighted Imaging of Radiation-Induced Brain Injury for Differentiation from Tumor Recurrence
AJNR 26:1455-1460,1305, Asao,C.,et al, 2005

Blinded Pressure and Pain
Lancet 365:2244, Rahim,S.A.,et al, 2005

Bells Palsy
BMJ 330:1374, Piercy, J, 2005

Thrombolytic Therapy of Acute Ischemic Stroke: Correlation of Angiographic Recanalization with Clinical Outcome
AJNR 26:880-884, Zaidat,O.O.,et al, 2005

Mechanical Thrombectomy for Acute Stroke
AJNR 26:875-879, Versnick,E.J.,et al, 2005

Cerebral MR Imaging in Uninfected Children Born to HIV-Seropositive Mothers and Perinatally Exposed to Zidovudine
AJNR 26:695-701,687, Tardieu,M.,et al, 2005

Primary CNS Lymphoma in Myasthenic on Long-term Azathioprine
J NeuroOncol 74:91-92, Finelli,P.F., 2005

Primary CNS Lymphoma Complicating Treatment of Myasthenia Gravis with Mycophenolate Mofetil
Neurol 65:639-641, Vernino,S.,et al, 2005

MRI Screening Before Standard Tissue Plasminogen Activator Therapy Is Feasible and Safe
Stroke 36:1939-1943, Kang,D.-W.,et al, 2005

REACH Clinical Feasibility of a Rural Telestroke Network
Stroke 36:2018-2020, Hess,D.C.,et al, 2005

Extracranial Arterial Dissection, Anticoagulation is the Treatment of Choice: For
Stroke 36:2041-2042,2043, Norris,J.W., 2005

Extracranial Arterial Dissection, Angicoagulation Is the Treatment of Choice: Against
Stroke 36:2042-2043,2043, Lyrer,P.A., 2005

Should a Patient With Primary Intracerebral Haemorrhage Receive Antiplatelet or Anticoagulant Therapy?
BMJ 331:439-442, Wani,M.,et al, 2005

Effect of Mitoxantrone on MRI in Progressive MS, Results of the MIMS Trial
Neurol 65:690-695, Krapf,H.,et al, 2005

Pathological Gambling Caused by Drugs Used to Treat Parkinson Disease
Arch Neurol 62:1377-1381, Dodd,M.L.,et al, 2005

Recent Use of Oral Contraceptives and the Risk of Multiple Sclerosis
Arch Neurol 62:1362-1365, Alonso,A.,et al, 2005

Time to Hospital Arrival, Use of Thrombolytics, and In-Hospital Outcomes in Ischemic Stroke
Neurol 64:2115-2120, Qureshi,A.I.,et al, 2005

Neurologic Manifestations in Welders with Pallidal MRI T1 Hyperintensity
Neurol 64:2033-2039,2001, Josephs,K.A.,et al, 2005

Transcranial Low-Frequency Ultrasound-Mediated Thrombolysis in Brain Ischemia
Stroke 36:1441-1446, Daffertshofer,M.,et al, 2005

Houston Paramedic and Emergency Stroke Treatment and Outcomes Study (HoPSTO)
Stroke 36:1512-1518, Wojner-Alexandrov,A.,et al, 2005



Showing articles 1800 to 1850 of 4563 << Previous Next >>